We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $1.49M invested in ESSA Pharma in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.01% more ownership
Funds ownership: 1.18% → 1.19% (+0.01%)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
21% less capital invested
Capital invested by funds: $1.9M → $1.49M (-$404K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17.9K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.15K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.15K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.68K |
| 3 |
Morgan Stanley
New York
|
-$2.6K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$68 |